BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 20580695)

  • 1. In vitro transcription of compound heterozygous hypofibrinogenemia Matsumoto IX; first identification of FGB IVS6 deletion of 4 nucleotides and FGG IVS3-2A>G causing abnormal RNA splicing.
    Terasawa F; Kamijyo Y; Fujihara N; Yamauchi K; Kumagai T; Honda T; Shigematsu S; Okumura N
    Clin Chim Acta; 2010 Sep; 411(17-18):1325-9. PubMed ID: 20580695
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A C-terminal amino acid substitution in the gamma-chain caused by a novel heterozygous frameshift mutation (Fibrinogen Matsumoto VII) results in hypofibrinogenaemia.
    Fujihara N; Haneishi A; Yamauchi K; Terasawa F; Ito T; Ishida F; Okumura N
    Thromb Haemost; 2010 Aug; 104(2):213-23. PubMed ID: 20589319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic analyses of novel compound heterozygous hypodysfibrinogenemia, Tsukuba I: FGG c.1129+62_65 del AATA and FGG c.1299+4 del A.
    Mukai S; Nagata K; Ikeda M; Arai S; Sugano M; Honda T; Okumura N
    Thromb Res; 2016 Dec; 148():111-117. PubMed ID: 27837696
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nonsense-mediated mRNA decay was demonstrated in two hypofibrinogenemias caused by heterozygous nonsense mutations of FGG, Shizuoka III and Kanazawa II.
    Soya K; Takezawa Y; Okumura N; Terasawa F
    Thromb Res; 2013 Oct; 132(4):465-70. PubMed ID: 24011387
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A deep intronic mutation in FGB creates a consensus exonic splicing enhancer motif that results in afibrinogenemia caused by aberrant mRNA splicing, which can be corrected in vitro with antisense oligonucleotide treatment.
    Davis RL; Homer VM; George PM; Brennan SO
    Hum Mutat; 2009 Feb; 30(2):221-7. PubMed ID: 18853456
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A G-to-A transition at the fifth position of intron-32 of the dystrophin gene inactivates a splice-donor site both in vivo and in vitro.
    Thi Tran HT; Takeshima Y; Surono A; Yagi M; Wada H; Matsuo M
    Mol Genet Metab; 2005 Jul; 85(3):213-9. PubMed ID: 15979033
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of hprt splicing mutations induced by the ultimate carcinogenic metabolite of benzo[a]pyrene in Chinese hamster V-79 cells.
    Hennig EE; Conney AH; Wei SJ
    Cancer Res; 1995 Apr; 55(7):1550-8. PubMed ID: 7882364
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Defective RNA splicing resulting from a mutation in the cyclic guanosine monophosphate-phosphodiesterase beta-subunit gene.
    Piriev NI; Shih JM; Farber DB
    Invest Ophthalmol Vis Sci; 1998 Mar; 39(3):463-70. PubMed ID: 9501854
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Novel Mutation in the Fibrinogen Bβ Chain (c.490G>A; End of Exon 3) Causes a Splicing Abnormality and Ultimately Leads to Congenital Hypofibrinogenemia.
    Taira C; Matsuda K; Arai S; Sugano M; Uehara T; Okumura N
    Int J Mol Sci; 2017 Nov; 18(11):. PubMed ID: 29156616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Congenital fibrinogen disorder with a compound heterozygote possessing two novel FGB mutations, one qualitative and the other quantitative.
    Yoda M; Kaido T; Taira C; Higuchi Y; Arai S; Okumura N
    Thromb Res; 2020 Dec; 196():152-158. PubMed ID: 32871307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel splice-site variant of the base excision repair gene MYH is associated with production of an aberrant mRNA transcript encoding a truncated MYH protein not localized in the nucleus.
    Tao H; Shinmura K; Hanaoka T; Natsukawa S; Shaura K; Koizumi Y; Kasuga Y; Ozawa T; Tsujinaka T; Li Z; Yamaguchi S; Yokota J; Sugimura H; Tsugane S
    Carcinogenesis; 2004 Oct; 25(10):1859-66. PubMed ID: 15180946
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The association of nonsense mutation with exon-skipping in hprt mRNA of Chinese hamster ovary cells results from an artifact of RT-PCR.
    Valentine CR; Heflich RH
    RNA; 1997 Jun; 3(6):660-76. PubMed ID: 9174100
    [TBL] [Abstract][Full Text] [Related]  

  • 13. N34S mutation in the SPINK1 gene is not associated with alternative splicing.
    Masamune A; Kume K; Takagi Y; Kikuta K; Satoh K; Satoh A; Shimosegawa T
    Pancreas; 2007 May; 34(4):423-8. PubMed ID: 17446841
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro expression of beta-thalassaemia gene (IVS1-1G>C) reveals complete inactivation of the normal 5' splice site and alternative aberrant RNA splicing.
    Fujihara N; Yamauchi K; Hirota-Kawadobora M; Ishikawa S; Tozuka M; Ishii E; Katsuyama T; Okumura N; Taniguchi S
    Ann Clin Biochem; 2007 Nov; 44(Pt 6):573-8. PubMed ID: 17961316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pseudo-exon activation caused by a deep-intronic mutation in the fibrinogen gamma-chain gene as a novel mechanism for congenital afibrinogenaemia.
    Spena S; Asselta R; Platé M; Castaman G; Duga S; Tenchini ML
    Br J Haematol; 2007 Oct; 139(1):128-32. PubMed ID: 17854317
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Erosive vitreoretinopathy and wagner disease are caused by intronic mutations in CSPG2/Versican that result in an imbalance of splice variants.
    Mukhopadhyay A; Nikopoulos K; Maugeri A; de Brouwer AP; van Nouhuys CE; Boon CJ; Perveen R; Zegers HA; Wittebol-Post D; van den Biesen PR; van der Velde-Visser SD; Brunner HG; Black GC; Hoyng CB; Cremers FP
    Invest Ophthalmol Vis Sci; 2006 Aug; 47(8):3565-72. PubMed ID: 16877430
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of in vitro splicing of the upstream intron by modifying an intra-exon sequence which is deleted from the dystrophin gene in dystrophin Kobe.
    Takeshima Y; Nishio H; Sakamoto H; Nakamura H; Matsuo M
    J Clin Invest; 1995 Feb; 95(2):515-20. PubMed ID: 7860733
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel splice-acceptor site mutation (IVS13-2A>T) of polycystic kidney disease 1 (PKD1) gene resulting in an RNA processing defect with a 74-nucleotide deletion in exon 14 of the mRNA transcript.
    Thongnoppakhun A; Rungroj N; Wilairat P; Vareesangthip K; Sirinavin C; Yenchitsomanus PT
    Hum Mutat; 2000 Jan; 15(1):115. PubMed ID: 10612835
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Abnormal splicing of hepatocyte nuclear factor 1 alpha in maturity-onset diabetes of the young.
    Bulman MP; Harries LW; Hansen T; Shepherd M; Kelly WF; Hattersley AT; Ellard S
    Diabetologia; 2002 Oct; 45(10):1463-7. PubMed ID: 12378390
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel G-to-A mutation in the intron-N of the protein S gene leading to abnormal RNA splicing in a patient with protein S deficiency.
    D'Andrea G; Di Perna P; Brancaccio V; Faioni EM; Castaman G; Cibelli G; Di Minno G; Margaglione M;
    Haematologica; 2003 Apr; 88(4):459-64. PubMed ID: 12681974
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.